LUIS RODRIGUEZ: Open Payments
NPI 1942881610 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 35 payments from 13 companies in 2025. Trend: 2023 $1,127 · 2024 $1,454 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $202 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Alkermes, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Almatica Pharma LLC | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Lundbeck LLC | 1 | $25 |
Products named: Auvelity, REXULTI, ARISTADA, COBENFY, CAPLYTA, INVEGA SUSTENNA, LOREEV XR, HETLIOZ.
Industry payments across FL — which companies pay providers there.
